Records containing: Idiopathic Parkinson Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study and Open-Label Extension to Evaluate the Safety and Efficacy of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease (NEULARK)
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase 2a, Single Site, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VTX3232 in Participants With Early-Stage Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-12-15Physiological Effects of Nutritional Support in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2025-09-19Adaptation Of The Parkinson's Disease Dyskinesia Questionnaire Into Turkish And Its Validity And Reliability In Parkinson's Patient
-
CLINICAL_TRIALS study record update · 2025-09-19Evaluating the Physiological and Psychological Effects of a Novel Meditation Technique on Cerebral Activity Measured With Functional Magnetic Resonance Imaging(fMRI) and F-18 Fluorodopa PET Imaging
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-09-09The Relationship of Prolactin and Inflammatory Markers With Parkinson's Disease Severity: Clinical and Biochemical Evaluation
-
CLINICAL_TRIALS study record update · 2025-08-07A Non-inferiority Open-labelled Crossover Randomized Controlled Trial, of Two Arms, to Investigate the Adhesiveness and Safety of Rotigexole 8 mg/24 Hours Transdermal Patch, Manufactured by Eva Pharma, Egypt, Compared to the Innovator Product, Neupro® 8 mg/ 24 Hours Transdermal Patch, Manufactured by UCB Pharma S.A., Belgium, After 24 Hours of Application
-
CLINICAL_TRIALS study record update · 2025-07-29Phase II: Physiological Effects of Nutritional Support in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2024-12-27Investigation the Effects of Sensory-Motor Integration Training on Cognitive Functions, Balance and Gait in Patients with Idiopathic Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2024-07-11A Phase 2 Study to Evaluate the Safety, Tolerability and Initial Efficacy of Pramipexole ER, Given With Aprepitant in Patients With Idiopathic Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2024-05-31Intravenous Young Fresh Frozen Plasma (yFFP) Investigational Treatment for Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2024-02-16A Cross-Sectional Study to Evaluate the Correlation Between Oculometric Measures and MDS-UPDRS in Patients With Idiopathic Parkinson's Disease (PD) and Evaluation of Oculometric Measures in Healthy Participants
-
CLINICAL_TRIALS study record update · 2024-02-13Sleep & Move. Systematic Characterisation of Sleep Benefit in Parkinson's Disease. An Observational, Prospective Study
-
CLINICAL_TRIALS study record update · 2023-09-22A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo-controlled, Single Ascending Dose Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06649751 In Subjects With Idiopathic Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2023-06-27Longitudinal Study of Molecular Pathology and Neuronal Networks in Leucine-rich Repeat Kinase 2 Carriers and Idiopathic Parkinson's Disease Patients and Healthy Controls Using PET, MR Imaging, and Other Markers of in Vivo Pathology
-
CLINICAL_TRIALS study record update · 2023-05-30A Comparison of Two Forms of Intensive Voice Treatment for Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2023-05-22A Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Safinamide 100mg Once Daily, as add-on Therapy, in Idiopathic Parkinson's Disease (PD) Patients With Motor Fluctuations and PD Related Chronic Pain
-
CLINICAL_TRIALS study record update · 2023-05-12The Natural History of Parkinson's Disease-associated Spinal Disorders
-
CLINICAL_TRIALS study record update · 2023-04-27A First-in-human, Double-blind, Placebo-controlled, Multicentre, Cross-over, Phase I Study to Assess Safety and Tolerability of Repeat Oral Administrations of MRx0029 OR MRx0005 in Adult Participants With Idiopathic Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2023-01-26Treatment of Parkinson Disease With Transplantation of SVF Cells of Adipose Origin: Safety and Exploratory Efficacy Study
-
CLINICAL_TRIALS study record update · 2022-10-12Physical Activity Behavior and Health-Related Quality of Life in Parkinson's Disease Patients: Role of Social Cognitive Variables
-
CLINICAL_TRIALS study record update · 2022-09-26Technology-Based Objective Measures for Gait and Postural Assessment in Parkinson Disease Patients With Orthostatic Hypotension: Feasibility and Effect-Size Finding Study
-
CLINICAL_TRIALS study record update · 2022-05-09Identification of Tear Biomarkers for Parkinson's Disease Patients
-
CLINICAL_TRIALS study record update · 2022-05-04Continued Support for Physical Activity in Everyday Life With Parkinson's Disease Using eHealth Technology
-
CLINICAL_TRIALS study record update · 2021-11-08Multicenter Study of Blood Biomarkers of Mitochondrial and Peroxisomal Metabolism to Differentiate Idiopathic Parkinson's Disease From Related Conditions